000			02130 a2200613 4500
005			20250515121955.0
264		0	_c20080703
008			200807s 0 0 eng d
022			_a1097-0215
024	7		_a10.1002/ijc.23543 _2doi
040			_aNLM _beng _cNLM
100	1		_avan Houdt, Inge S
245	0	0	_aFavorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. _h[electronic resource]
260			_bInternational journal of cancer _cAug 2008
300			_a609-15 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntigen-Presenting Cells _ximmunology
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aBiopsy
650	0	4	_aCD4 Antigens _xanalysis
650	0	4	_aCD56 Antigen _xanalysis
650	0	4	_aCD8 Antigens _xanalysis
650	0	4	_aFemale
650	0	4	_aGranzymes _xanalysis
650	0	4	_aHistocompatibility Antigens Class I _xanalysis
650	0	4	_aHistocompatibility Antigens Class II _xanalysis
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLymphatic Metastasis
650	0	4	_aLymphocyte Activation
650	0	4	_aLymphocytes, Tumor-Infiltrating
650	0	4	_aMale
650	0	4	_aMelanoma _ximmunology
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aSkin Neoplasms _ximmunology
650	0	4	_aTreatment Outcome
700	1		_aSluijter, Berbel J R
700	1		_aMoesbergen, Laura M
700	1		_aVos, Wim M
700	1		_ade Gruijl, Tanja D
700	1		_aMolenkamp, Barbara G
700	1		_avan den Eertwegh, Alfons J M
700	1		_aHooijberg, Erik
700	1		_avan Leeuwen, Paul A M
700	1		_aMeijer, Chris J L M
700	1		_aOudejans, Joost J
773	0		_tInternational journal of cancer _gvol. 123 _gno. 3 _gp. 609-15
856	4	0	_uhttps://doi.org/10.1002/ijc.23543 _zAvailable from publisher's website
999			_c17991892 _d17991892